NOXAFIL (posaconazole) Patient Assistance Program
Don’t let the high cost of brand specialty antifungal therapy disrupt your treatment. We help eligible patients access Noxafil (posaconazole) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Noxafil (posaconazole) is FDA-approved for prophylaxis of invasive Aspergillus and Candida infections in high-risk immunocompromised patients (≥13 years), oropharyngeal candidiasis (including fluconazole-refractory), and as treatment for invasive aspergillosis in adults (delayed-release tablets and IV). Available as oral suspension, delayed-release tablets, IV solution.
- Without assistance, Noxafil costs commonly run approximately $1,500–$3,500 per 30-day supply depending on formulation and dose.
- Through AffordMyPrescriptions, qualifying patients can access Noxafil for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic posaconazole delayed-release tablets are now available in the U.S. at substantially lower cost. Other extended-spectrum triazoles include voriconazole (Vfend, generic available) and isavuconazole (Cresemba). Fluconazole (generic, very cheap) covers many Candida species but not Aspergillus or many resistant molds.
What Is Noxafil Prescription Assistance Program?
The Noxafil Prescription Assistance Program is a manufacturer-sponsored initiative that provides Noxafil at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for immunocompromised patients requiring antifungal prophylaxis or treatment who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, infectious disease/oncology/transplant coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and re-certification.
Pharmacy Price Comparison
- Without assistance, Noxafil costs roughly $1,500–$3,500/month. Generic posaconazole DR tablets are cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$3,200 | Save substantially |
| CVS Pharmacy (brand) | $3,500 | Save substantially |
| Walmart (brand) | $1,800 | Save substantially |
| Costco (brand) | ~$1,700 | Save substantially |
Generic posaconazole DR | ~$500 | Generic — lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Noxafil Prescription Program?
The Patient Assistance Program is free to apply for and provides Noxafil at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic posaconazole delayed-release tablets now available at lower cost, we’ll help your provider determine the best path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Noxafil:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $1,500–$3,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Noxafil assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Noxafil Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Noxafil:
Noxafil (posaconazole) is an oral and IV extended-spectrum triazole antifungal used for prevention and treatment of invasive fungal infections — particularly Aspergillus species and Candida — in immunocompromised patients (stem cell transplant, hematologic malignancy with prolonged neutropenia, solid organ transplant, advanced HIV). It also has activity against some less common molds.
How Lovenox Works:
Fungal infections pose serious risks to immunocompromised patients, making prophylactic therapy essential to reduce invasive infections during high-risk periods like neutropenia. Posaconazole works by blocking ergosterol synthesis in the fungal cell membrane, rendering the membrane dysfunctional and causing the fungi to die. It features broad-spectrum activity against Aspergillus, most Candida species, and various other molds and dimorphic fungi. The delayed-release tablet formulation offers more reliable absorption than the older oral suspension.
Form and use:
Noxafil is available as delayed-release (DR) tablets, an oral suspension, and an intravenous (IV) formulation. The DR tablets and IV version are typically dosed at 300 mg twice daily on day one, followed by 300 mg once daily for prophylaxis. The oral suspension requires a dose of 200 mg three times daily and must be taken with a high-fat meal or nutritional supplement due to food-dependent absorption. Because of its more reliable absorption, the DR tablet is generally preferred over the suspension for most adult patients.
Generic availability:
Generic posaconazole delayed-release tablets are currently available in the U.S. at a substantially lower cost than the brand-name Noxafil. Other extended-spectrum triazole options include voriconazole for invasive aspergillosis, isavuconazole for mucormycosis, and the older itraconazole. Fluconazole is a very cheap generic alternative that covers many Candida species but fails to target Aspergillus or most molds. Additionally, IV echinocandins like caspofungin, micafungin, and anidulafungin are available to cover Candida and some Aspergillus.
Warnings:
Noxafil requires regular monitoring due to warnings regarding hepatotoxicity, QT prolongation, arrhythmias like torsades de pointes, and electrolyte abnormalities. Rare mineralocorticoid effects, such as pseudo-hyperaldosteronism causing hypertension and hypokalemia, can also occur with prolonged use or high doses. Furthermore, it acts as a potent CYP3A4 inhibitor, leading to significant and sometimes contraindicated drug interactions with medications like statins, vincristine, and calcineurin inhibitors.
FAQ (Frequently Asked Questions)
How Much Does Noxafil Cost Without Insurance?
Brand Noxafil costs approximately $1,500–$3,500 per 30-day supply depending on formulation and dose. Generic posaconazole delayed-release tablets are substantially cheaper. Through AffordMyPrescriptions, qualifying patients receive Noxafil at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Is Generic Posaconazole The Same As Brand Noxafil?
Yes. The FDA approves generic posaconazole delayed-release tablets as bioequivalent to brand Noxafil. Most infectious disease physicians and transplant teams are comfortable with generic. Most insurance plans prefer generic.
Why The Delayed-Release Tablet Instead Of The Oral Suspension?
The DR tablet has more consistent absorption than the oral suspension (which is highly food-dependent). For most adult patients, the DR tablet is preferred. The oral suspension is still used in some pediatric patients, patients with swallowing difficulty, or when a feeding tube is in use. With either formulation, taking with food (especially high-fat) maximizes absorption.
Are There Drug Interactions I Should Know About?
Yes — many. Posaconazole is a potent CYP3A4 inhibitor — it raises levels of many co-administered medications. Calcineurin inhibitors (tacrolimus, cyclosporine), sirolimus, vincristine, statins (atorvastatin, lovastatin, simvastatin — some contraindicated), midazolam, ergot alkaloids, certain antiarrhythmics, and many others have significant interactions. Some combinations are contraindicated. Tell every prescriber and pharmacist about Noxafil.
How Long Will I Be On Noxafil?
Prophylaxis duration depends on indication: throughout neutropenia in stem cell transplant or AML/MDS chemotherapy (often weeks to months), until adequate immune recovery in advanced HIV (typically months), throughout GVHD treatment in transplant patients (often months). Treatment of established invasive aspergillosis is typically extended (weeks to months) based on response.
Can I Get Noxafil Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic posaconazole (much cheaper), generic voriconazole, generic itraconazole, or generic fluconazole (if narrower spectrum coverage is sufficient), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Leukemia & Lymphoma Society, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Noxafil, our team may be able to help you access assistance programs — or guide you to generic posaconazole. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.